Jubilant Life Sciences Limited, is an integrated global pharmaceutical and life sciences company. The Company’s strength lies in its unique offerings of Pharmaceutical and Life Sciences products and services.
Jubilant Life Sciences' progress in diverse businesses has been made possible through the combination of R&D, command over cheap technologies and economies of scale into a synergistic organic entity, continuously creating and nurturing high quality products and technologies.
Jubilant’s approach to sustainable development focuses on the triple bottom line of Economics, Environment and Social performance. The company is committed to and works on various areas for energy conservation and climate change mitigation. These sustainability efforts have been reported through a Corporate Sustainability Report since 2003 and this report has been receiving GRI G3.1 A+ level and GRI Check, since 2007 from Global Reporting Initiative (GRI). This reflects Jubilant Life Sciences commitment towards sustainable development and continued efforts directed towards protecting the environment in which it operates.
CSR initiatives of the Company are conceptualized and implemented through Jubilant Bhartia Foundation ('JBF'), the social wing of Jubilant Bhartia Group, established in 2007 as a not-for-profit organization.
The Committee approved the following CSR activities which are in line with Schedule VII to the Act:
• Project Arogya and Swasthya Prahari: Improving health indices through innovative services and promoting health seeking behavior;
• Project Muskaan: Universalising elementary education and improving quality parameters for primary education through community involvement;
• Nayee Disha: Enhancing employability through vocational training; and
• Rural Development: Supporting the community infrastructure as and when identified in the project area.